OncoMyx Therapeutics Funding: $75M Raised, Series B (2021)
OncoMyx Therapeutics is based in Phoenix, AZ. It has raised $75M in total funding. Latest round: Series B.
OncoMyx Therapeutics funding overview
OncoMyx Therapeutics is based in Phoenix, AZ. OncoMyx Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2021. The round record for OncoMyx Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lumira Ventures, B Capital Group, Boehringer Ingelheim Venture Fund, Delos Capital, Xeraya Capital, Korea Investment Partners and 3 others. 9 distinct backers are named across the disclosed rounds.
OncoMyx Therapeutics at a glance
Total raised
$75M
Latest round
Series B
Latest round date
December 2021
Headquarters
Phoenix, AZ
Notable investors
Lumira Ventures, B Capital Group, Boehringer Ingelheim Venture Fund, Delos Capital, Xeraya Capital, Korea Investment Partners, City Hill Ventures, Madison Partners
Frequently asked about OncoMyx Therapeutics funding
How much has OncoMyx Therapeutics raised?
OncoMyx Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in OncoMyx Therapeutics?
Lumira Ventures, B Capital Group, Boehringer Ingelheim Venture Fund, Delos Capital, Xeraya Capital, Korea Investment Partners are named among the investors backing OncoMyx Therapeutics.
What was the latest OncoMyx Therapeutics funding round?
The most recent disclosed round is a Series B, announced in December 2021.
Where is OncoMyx Therapeutics based?
OncoMyx Therapeutics is based in Phoenix, AZ.
When did OncoMyx Therapeutics last raise?
The last disclosed OncoMyx Therapeutics round closed in December 2021 at Series B.
Totals shown for OncoMyx Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Phoenix and the investors behind them below.
